WALGREENS BOOTS ALLIANCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up
WBA
US9314271084
Drug Retailers| Real-time Estimate Cboe BZX Other stock markets | 5-day change | 1st Jan Change | ||
| 15.92 USD | -0.09% |  | -0.99% | -38.91% |
| Jun. 10 | Global markets live: ABB, Roche, Microsoft, Apple, Tesla... |  |
| Jun. 08 | Walgreens Reportedly Shelves Plans for Boots IPO as Sale Talks Continue | CI |
Financials (USD)
| Sales 2024 * | 145B | Sales 2025 * | 151B | Capitalization | 13.75B |
|---|---|---|---|---|---|
| Net income 2024 * | -7.18B | Net income 2025 * | 1.81B | EV / Sales 2024 * | 0.14x |
| Net Debt 2024 * | 7.17B | Net Debt 2025 * | 6.78B | EV / Sales 2025 * | 0.14x |
| P/E ratio 2024 * | -1.9x | P/E ratio 2025 * | 8.14x | Employees | 268,500 |
| Yield 2024 * | 8.87% | Yield 2025 * | 6.51% | Free-Float | 60.75% |
More Fundamentals * Assessed data
Chart Walgreens Boots Alliance, Inc.
Dynamic Chart
Latest news about Walgreens Boots Alliance, Inc.
| Global markets live: ABB, Roche, Microsoft, Apple, Tesla... | | |
| Walgreens Reportedly Shelves Plans for Boots IPO as Sale Talks Continue | CI | |
| Top law firms in US opioid lawsuits to get hundreds of millions in fees | RE | |
| CityMD Agrees to $12 Million to Pay Department of Justice Over Alleged Covid-19 Payments Violation | DJ | |
| CityMD Agrees to $12 Million to Pay Department of Justice Over Alleged Covid-19 Payments Violation -- Update | DJ | |
| Sector Update: Health Care Stocks Higher Late Afternoon | MT | |
| Sector Update: Health Care | MT | |
| Walgreens Shelves Boots IPO Plans, Explores Other Options | MT | |
| Walgreens Shelves Boots IPO Plans, Explores Other Options | MT | |
| Walgreens shelves plans for Boots IPO, Bloomberg News reports | RE | |
| Walgreens to Shelve Boots IPO Plans as Sale Talks Continue, Bloomberg Says | MT | |
| Leerink Adjusts Price Target on Walgreens Boots Alliance to $17 From $22 | MT | |
| Evercore ISI Adjusts Price Target on Walgreens Boots Alliance to $17 From $18, Keeps In Line Rating | MT | |
| Morgan Stanley Lowers Price Target on Walgreens Boots Alliance to $13 From $16, Maintains Underweight Rating | MT | |
| Price cuts, weaker spending may boost Fed's faith in inflation outlook | RE |
More news
Latest transcript on Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc., Q2 2024 Earnings Call, Mar 28, 2024
More transcripts
Analyst Recommendations on Walgreens Boots Alliance, Inc.
| Leerink Adjusts Price Target on Walgreens Boots Alliance to $17 From $22 | MT | |
| Evercore ISI Adjusts Price Target on Walgreens Boots Alliance to $17 From $18, Keeps In Line Rating | MT | |
| Morgan Stanley Lowers Price Target on Walgreens Boots Alliance to $13 From $16, Maintains Underweight Rating | MT | |
| TD Cowen Adjusts Price Target on Walgreens Boots Alliance to $35 From $37 | MT | |
| HSBC Adjusts Price Target on Walgreens Boots Alliance to $16 From $20 | MT |
More recommendations
Press releases Walgreens Boots Alliance, Inc.
| Walgreens Boots Alliance Schedules Fiscal 2024 Third Quarter Earnings Announcement for June 27 | BU | |
| Walgreens En Tu Comunidad, Fosters Community in Puerto Rico with Health Fair Aimed to Increase Access and Education of Certain Health Services | AQ | |
| Walgreens Introduces Summer of Savings | BU | |
| “Walgreens En Tu Comunidad” Fosters Community in Puerto Rico with Health Fair Aimed to Increase Access and Education of Certain Health Services | BU | |
| Walgreens Boots Alliance Sells Shares of Cencora for $400 Million of Proceeds | BU |
More press releases
News in other languages on Walgreens Boots Alliance, Inc.
| Le jour de la marmotte | ||
| En Direct des Marchés : Stellantis, Crédit Agricole, LVMH, Volvo, Microsoft, Apple, Southwest Airlines... | ||
| Borsa di Italia: Il giorno della marmotta | ||
| Bolsa de Madrid: El día de la marmota | ||
| Nvidia Corp.: Bald im Dow Jones? |
More news
Quotes and Performance
| 1 day | -0.35% | ||
| 1 week | +0.13% | ||
| Current month | -1.73% | ||
| 1 month | -7.27% | ||
| 3 months | -24.67% | ||
| 6 months | -31.17% | ||
| Current year | -38.95% |
More quotes
Highs and lows
1 week
15.61
16.10
1 month
14.62
18.83
Current year
14.62
27.05
1 year
14.62
32.89
3 years
14.62
55.10
5 years
14.62
64.50
10 years
14.62
97.30
More quotes
Managers and Directors - Walgreens Boots Alliance, Inc.
| Managers | Title | Age | Since |
|---|---|---|---|
Timothy Wentworth CEO | Chief Executive Officer | 64 | 23-10-22 |
Manmohan Mahajan DFI | Director of Finance/CFO | 45 | 16-01-31 |
Stefano Pessina CHM | Chairman | 83 | 12-07-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Bryan Hanson BRD | Director/Board Member | 57 | 22-10-26 |
Valerie Jarrett BRD | Director/Board Member | 67 | 20-10-28 |
Ginger Graham BRD | Director/Board Member | 68 | 10-03-31 |
More insiders
Quotes
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-11 | 15.97 | +0.19% | 978 230 |
| 24-06-10 | 15.94 | +0.63% | 9,607,627 |
| 24-06-07 | 15.84 | -0.13% | 8,431,777 |
| 24-06-06 | 15.86 | -0.50% | 7,163,328 |
| 24-06-05 | 15.94 | -1.06% | 8,948,954 |
Delayed Quote Nasdaq, June 10, 2024 at 04:00 pm EDT
More quotes
Company Profile
Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows:- retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.9% of net sales) and internationally (9.1%). At the end of August 2023, the activity is carried out through 13,532 outlets (of which 8,706 located in the United States, Puerto Rico and the US Virgin Islands), and through the Internet;- wholesale distribution (8.1%).The remaining sales (4.7%) are from the healthcareNet sales break down geographically as follows: the United States (84%), Germany (8.1%), the United Kingdom (6.5%) and other (1.4%).
Sector
Drug Retailers
Calendar
2024-06-27 - Q3 2024 Earnings Release
Related indices
More about the company
Income Statement Evolution
More financial data
Analysis / Opinion
More Strategies
Ratings for Walgreens Boots Alliance, Inc.
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Analysts' Consensus
Sell
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
15.94USD
Average target price
22.21USD
Spread / Average Target
+39.32%
Consensus
EPS Revisions
Estimates Revisions
Quarterly earnings - Rate of surprise
Company calendar
Sector Other Drug Retailers
| 1st Jan change | Capi. | |
|---|---|---|
WALGREENS BOOTS ALLIANCE, INC. | -38.95% | 13.75B |
JD HEALTH INTERNATIONAL INC. | -36.45% | 10.33B |
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED | -10.85% | 7.94B |
YIFENG PHARMACY CHAIN CO., LTD. | +4.90% | 5.86B |
| -14.80% | 5.69B | |
NAHDI MEDICAL COMPANY | -2.04% | 4.65B |
CORPORATIVO FRAGUA, S.A.B. DE C.V. | +69.95% | 4.46B |
CLICKS GROUP LIMITED | -8.55% | 3.79B |
DASHENLIN PHARMACEUTICAL GROUP CO., LTD. | -22.05% | 3.05B |
WELCIA HOLDINGS CO., LTD. | -14.21% | 2.83B |
Other Drug Retailers
- Stock Market
- Equities
- WBA Stock
